Search results
ArriVent partners Alphamab to develop ADCs for cancer
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoArriVent BioPharma has entered a partnership with Alphamab Oncology subsidiary Jiangsu Alphamab...
Ambrx Biopharma Has Surged 522% This Year. But It Could Just Be Getting Started.
Investor's Business Daily· 10 months agoAmbrx Biopharma is no longer flying under the radar. Instead, AMAM stock has soared 522% this year...
Adcentrx receives NMPA approval for solid tumour therapy trial
Clinical Trials Arena via Yahoo Finance· 1 month agoChina’s National Medical Products Administration (NMPA) has approved an Investigational New Drug...
The Orville Finale Promo Teases a Rekindling (and a Special Occasion)
TVLine.com via Yahoo News· 2 years agoBig things are happening in The Orville‘s Season 3 finale — and we’re not just talking about Isaac...
Fluor (FLR) Divests AMECO South America Business, Stock Down
Zacks via Yahoo Finance· 1 year agoFluor Corporation’s FLR shares fell 0.8% in an after-hours trading session on Mar 14, post its...
After being diagnosed with cyclothymia at age 30, I kept my struggles a secret. I was raised to...
INSIDER via Yahoo News· 2 years agoCourtesy of Yvonne Liu I've struggled with depression, but kept it secret because that's what my...
Gwyneth Paltrow marks Apple’s 19th birthday with 'fitting' double celebration
TODAY via Yahoo News· 1 year agoGwyneth Paltrow celebrated her daughter Apple's 19th birthday on Mother's Day. The Oscar winner, 50,...
Rubius Therapeutics Shifts Its Clinical Focus, Pulls Plug On Two Early-Stage Cancer Assets
Benzinga via Yahoo Finance· 2 years agoRubius Therapeutics Inc (NASDAQ: RUBY) announced plans to restructure and align resources to advance...
Nurix (NRIX) Stock Increases 9% in a Month: Here's Why
Zacks via Yahoo Finance· 9 months agoThe upside in Nurix's (NRIX) shares can be attributed to the company's recently signed collaboration...
Acepodia reports preliminary results from ACE1831 Phase I trial
Clinical Trials Arena via Yahoo Finance· 1 month agoClinical-stage biotechnology company Acepodia has reported preliminary results from the Phase I...